Thermo fisher scientific expands oral solid dose development and manufacturing capabilities across north america

Cincinnati & bend, ore.--(business wire)--to provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, thermo fisher scientific inc. is expanding its oral solid dose (osd) footprint with a $22-million total investment since 2021 in its cincinnati, ohio, and bend, ore. sites. together, these expansions will enable research and development (r&d), manufacturing and testing of osd drug formulations – doubling the bend site.
TMO Ratings Summary
TMO Quant Ranking